Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Exchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Amicus Therapeutics (FOLD) Other Working Capital Changes (2016 - 2025)

Historic Other Working Capital Changes for Amicus Therapeutics (FOLD) over the last 16 years, with Q3 2025 value amounting to -$7.6 million.

  • Amicus Therapeutics' Other Working Capital Changes rose 4690.33% to -$7.6 million in Q3 2025 from the same period last year, while for Sep 2025 it was $15.0 million, marking a year-over-year increase of 13258.38%. This contributed to the annual value of -$14.0 million for FY2024, which is 27317.04% down from last year.
  • Per Amicus Therapeutics' latest filing, its Other Working Capital Changes stood at -$7.6 million for Q3 2025, which was up 4690.33% from $4.8 million recorded in Q2 2025.
  • Amicus Therapeutics' Other Working Capital Changes' 5-year high stood at $15.0 million during Q4 2021, with a 5-year trough of -$19.3 million in Q2 2024.
  • Moreover, its 5-year median value for Other Working Capital Changes was $1.1 million (2022), whereas its average is $368473.7.
  • Examining YoY changes over the last 5 years, Amicus Therapeutics' Other Working Capital Changes showed a top increase of 114745.92% in 2023 and a maximum decrease of 303747.95% in 2023.
  • Over the past 5 years, Amicus Therapeutics' Other Working Capital Changes (Quarter) stood at $15.0 million in 2021, then tumbled by 95.93% to $611000.0 in 2022, then crashed by 3037.48% to -$17.9 million in 2023, then soared by 179.42% to $14.3 million in 2024, then tumbled by 153.1% to -$7.6 million in 2025.
  • Its Other Working Capital Changes was -$7.6 million in Q3 2025, compared to $4.8 million in Q2 2025 and $3.6 million in Q1 2025.